Atlas Trials

Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)

Clinical trial NCT04051268 · COMPLETED

Trial details

NCT number
NCT04051268
Sponsor
PT Bio Farma
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Safety IssuesImmunogenicity
Start date
2020-03-02
Primary completion
2021-11-24
Enrollment
3071

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.